Reply to Li and Jiang: Comment on Long-Term Pulmonary Sequelae Following Severe COVID-19: Reflections on Study Design and Interpretation [0.03%]
对李文和江头提出的关于严重COVID-19后长期肺部后遗症的反思：研究设计与解读的意见回复
Matthew R Baldwin,Christine Kim Garcia
Matthew R Baldwin
Reply to Gottlieb and Fuehner: Preoxygenation and High flow Oxygen Therapy During Bronchoscopy Under Procedural Sedation in Patients with Central Airway Obstruction [0.03%]
对Gottlieb和Fuehner的观点的回应：程序镇静下纤支镜检查中预给氧和高流量吸氧治疗的作用
Hao Qin,Wei Zhang,Guoqiang Jing et al.
Hao Qin et al.
Preoxygenation and High Flow Oxygen Therapy During Bronchoscopy Under Procedural Sedation in Patients with Central Airway Obstruction [0.03%]
支气管镜镇静下中央气道阻塞患者的预氧合与高流量吸氧疗法
Jens Gottlieb,Thomas Fuehner
Jens Gottlieb
Reply to Borrás-Blasco et al.: How Adherence Shapes Persistence in IPF Treatment: A Call for Real-World Insight [0.03%]
针对Borrás-Blasco等人的回复：坚持度与特发性肺纤维化治疗顺应性的关系——来自真实世界数据的启示呼吁
Tejaswini Kulkarni,Kevin Flaherty,Sachin Gupta et al.
Tejaswini Kulkarni et al.
How Adherence Shapes Persistence in IPF Treatment: A Call for Real-World Insight [0.03%]
坚持与依从相互影响决定IPF治疗的前景——呼吁借鉴现实世界的洞见
Joaquín Borrás-Blasco,Alejandro Valcuende-Rosique,Silvia Cornejo
Joaquín Borrás-Blasco
Health Inequity in People with Cystic Fibrosis: Can We Close the Gap? [0.03%]
cystic fibrosis患者的健康不公平：我们能弥合差距吗？
Isabelle Sermet-Gaudelus,Annalisa Orenti,Elpis Hatziagorou et al.
Isabelle Sermet-Gaudelus et al.
Background Although advances in care have improved cystic fibrosis (CF) outcomes in higher-income countries (HICs), the situation remains alarming in lower-income countries (LICs). Methods People with CF (pwCF) enrolled in the European Cyst...
Nocturnal Oxygen Therapy for Central Sleep Apnea in Patients with Heart Failure: A Multi-site, Double-blind, Sham-controlled Randomized Clinical Trial (LOFT-HF) [0.03%]
序贯适应性正压通气治疗心力衰竭中央型睡眠呼吸暂停的多中心、双盲随机对照试验（LOFT-HF）
Susan Redline,Dongdong Li,Shahrokh Javaheri et al.
Susan Redline et al.
Rationale: There are insufficient data to inform the management of central sleep apnea (CSA) in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Nocturnal oxygen therapy (NOT) has been postulated t...
Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension [0.03%]
昼夜差异对肺动脉高压患者评估的影响
Cyrus Vahdatpour,Shiza Virk,Haocheng Ding et al.
Cyrus Vahdatpour et al.
Background: Pulmonary hypertension (PH) is a systemic illness with increasingly subtle disease manifestations including sleep disruption. Patients with PH are at increased risk for disturbances in circadian biology, altho...
Co-morbid Insomnia and Sleep Apnea Is Associated with Uncontrolled Hypertension in a Middle-aged Population [0.03%]
中年人群并存的失眠和睡眠呼吸障碍与未控制高血压有关
Mio Kobayashi Frisk,Joel Bergqvist,Sven Svedmyr et al.
Mio Kobayashi Frisk et al.
Introduction: Co-morbid insomnia and sleep apnea (COMISA) has been linked to poorer health outcomes and increased all-cause mortality compared with either insomnia or obstructive sleep apnea (OSA) alone. ...